TITLE

Screening for Hepatocellular Carcinoma in Patients With Cirrhosis in the United States: Results of a National Survey

AUTHOR(S)
Chalasani, Naga; Said, Areen; Ness, Reid; Hoen, Helena; Lumeng, Lawrence
PUB. DATE
August 1999
SOURCE
American Journal of Gastroenterology;Aug1999, Vol. 94 Issue 8, p2224
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the dreaded complications of cirrhosis. Although there are no randomized controlled studies showing improved survival with screening, patients with cirrhosis are screened for HCC. Little is known about the practice of HCC screening in the United States. Our aim was to describe the practice of HCC screening in patients with cirrhosis in the United States. METHODS: In March 1998, we mailed a standard questionnaire to 1021 physician members of the American Association of Study for Liver Diseases and the same questionnaire was re-sent to nonrespondents 4 weeks later. RESULTS: We received a response from 554 members (54%). After excluding those not involved in active adult patient care, 473 responses were eligible for analysis. Eighty-four percent of the respondents routinely screened patients with cirrhosis for HCC (screening respondents). Nearly half of the screening respondents limited the HCC screening to patients with high-risk etiologies such as hepatitis B or C or hemochromatosis. Although alpha-fetoprotein (99.7%) and ultrasound (93%) were the two most frequently used screening methods, a sizable proportion of the screening respondents (25%) used abdominal computed tomography for routine screening. On multivariate analysis, the following variables predicted screening for HCC by the respondents: seeing more than one new cirrhotic per week (odds ratio [OR]: 5.4, 95% confidence interval [CI]: 2.5-11.7); practicing for < 10 yr (OR: 4.0, 95% CI: 1.2-13.4); an opinion that screening is cost-effective (OR: 6.4, 95% CI: 1.6-25); an opinion that screening prolongs survival (OR: 5.7, 95% CI: 1.8-17.9); and an opinion that not screening poses malpractice liability (OR: 9.3, 95% CI: 4.2-20.8). CONCLUSIONS: The majority of respondents routinely screen patients with cirrhosis for HCC. Approximately half of the screening respondents limit their screening to only patients with high-risk etiologies. On multivariate analysis, several variables predicted screening for HCC by the respondents.
ACCESSION #
17830909

 

Related Articles

  • Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Patwardhan, Vilas; Paul, Sonali; Corey, Kathleen; Mazhar, Sameer; Richter, James; Thiim, Michael; Chung, Raymond; Corey, Kathleen E; Mazhar, Sameer M; Richter, James M; Chung, Raymond T // Digestive Diseases & Sciences;Nov2011, Vol. 56 Issue 11, p3316 

    Background: Regular screening of cirrhotic patients for hepatocellular carcinoma (HCC) has been suboptimal, but there is little data regarding specific risk factors for reduced screening.Methods: From 1996 to 2010, patients with cirrhosis were retrospectively identified...

  • Hepatocellular Carcinoma. Desjardins, Lisa A. // Clinical Journal of Oncology Nursing;Mar/Apr2002, Vol. 6 Issue 2, p107 

    Provides information on hepatocellular carcinoma (HCC), a common malignancy and a disease of multifactorial etiology. Risk factors for HCC; Treatment and prevention; Screening of HCC.

  • Risk of liver cancer among US male veterans with cirrhosis, 1969-1996. Persson, E C; Quraishi, S M; Welzel, T M; Carreon, J D; Gridley, G; Graubard, B I; McGlynn, K A // British Journal of Cancer;6/26/2012, Vol. 107 Issue 1, p195 

    Background:Liver cancer incidence rates in the United States have increased for several decades for reasons that are not entirely clear. Regardless of aetiology, cirrhosis is a strong risk factor for liver cancer. As mortality from cirrhosis has been declining in recent decades, it is possible...

  • Hepatic and Extrahepatic Cancer in Cirrhosis: A Longitudinal Cohort Study. Berman, Kenneth; Tandra, Sweta; Vuppalanch, Raj; Ghabril, Marwan; Sandrasegaran, Kumaresan; Nguyen, James; Caffrey, Helena; Liangpunsakul, Suthat; Lumeng, Lawrence; Kwo, Paul; Chalasani, Naga // American Journal of Gastroenterology;May2011, Vol. 106 Issue 5, p899 

    OBJECTIVES:We conducted a retrospective cohort study in cirrhotic patients to understand (i) the risk of developing hepatocellular carcinoma (HCC) after an initial negative screening computed tomography (CT) scan and its relationship with underlying etiology and (ii) the risk of extrahepatic...

  • Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence. Caillot, Frédérique; Derambure, Céline; Bioulac-Sage, Paulette; François, Arnaud; Scotte, Michel; Goria, Odile; Hiron, Martine; Daveau, Maryvonne; Salier, Jean-Philippe; Luk, John M. // World Journal of Gastroenterology;1/21/2009, Vol. 15 Issue 3, p300 

    AIM: To search for transcription dysregulation that could (1) differentiate hepatocellular carcinoma (HCC)-free from HCC-related cirrhosis (2) differentiate HCC-free cirrhosis related to HCV from that related to alcohol intake. METHODS: Using microarray analysis, we compared transcript levels in...

  • Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Benvegnà, L.; Gios, M.; Boccato, S.; Alberti, A. // Gut;May2004, Vol. 53 Issue 5, p744 

    Background and aims: The natural history of initially compensated cirrhosis due to hepatitis B (HBV) or hepatitis C (HCV) virus is only partially defined. We have investigated morbidity and mortality rates and the hierarchy of complications in compensated viral cirrhosis over a long follow up...

  • Breast Cancer Developed in a Male Patient With Liver Cirrhosis Bearing Hepatocellular Carcinoma. Yoneda, Satoshi; Yoshikawa, Masahide; Yamane, Yoshiko; Nakatani, Toshiya; Iwasawa, Shu; Nishimura, Kimio; Watanabe, Iwao; Fukui, Hiroshi; Enoki, Noburu // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p556 

    Presents the case study of a 55-year-old Japanese man with liver cirrhosis complicated with hepatocellular carcinoma, who developed breast cancer. Findings of the physical examination on the patient; Factors that played an important etiological role in the development of breast cancer in men.

  • An expanded view of congenital heart disease. Greenberg, S. // International Journal of Cardiovascular Imaging;Aug2014, Vol. 30 Issue 6, p1085 

    No abstract available.

  • Impact of Etiology of Cirrhosis on the Survival of Patients Diagnosed With Hepatocellular Carcinoma During Surveillance. Trevisani, Franco; Magini, Giulia; Santi, Valentina; Morselli-Labate, Antonio Maria; Chiara Cantarini, Maria; Anna Di Nolfo, Maria; Del Poggio, Paolo; Benvegn, Luisa; Rapaccini, Gianludovico; Farinati, Fabio; Zoli, Marco; Borzio, Franco; Giovanni Giannini, Edoardo; Caturelli, Eugenio; Bernardi, Mauro // American Journal of Gastroenterology;May2007, Vol. 102 Issue 5, p1022 

    OBJECTIVES: Although the etiology of liver disease affects the features of hepatocellular carcinoma (HCC) diagnosed during surveillance, it is not known whether it influences patients' survival. We analyzed the impact of etiology on the characteristics and outcome of HCC detected during...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics